NCT03885362View on ClinicalTrials.gov

Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions

Diabetic NephropathiesType 1 Diabetes MellitusChronic Kidney Diseases

Interventions

DEVICE

Dexcom G6 and Abbott Freestyle Libre

Dexcom G6 - continuous glucose monitoring device - blinded. CE mark 2018 Abbott Freestyle Libre - flash glucose monitoring device. CE mark 2014

Trial Locations (1)

Unknown

Imperial College London/NHS trust Renal Unit, London

All Listed Sponsors

lead

Imperial College London

OTHER

NCT03885362 - Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis | Biotech Hunter | Biotech Hunter